HWAM
PAHC icon

Hennion & Walsh Asset Management’s Phibro Animal Health PAHC Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,669
Closed -$203K – 995
2026
Q1 		$203K Buy
+3,669
New +$175K 0.01% 898

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Hennion & Walsh Asset Management's PAHC Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 3,669 shares — an estimated $203K sold.

Hennion & Walsh Asset Management first reported a position in PAHC in Q1 2026 and held it in 1 quarter. The position peaked at $203K in Q1 2026. 92 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 3,669 Phibro Animal Health shares in Q2 2026, an estimated $203K.
  • Hennion & Walsh Asset Management first reported a position in Phibro Animal Health in Q1 2026 and held it in 1 quarter.
  • Hennion & Walsh Asset Management's Phibro Animal Health position peaked at $203K in Q1 2026.
  • 92 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.